ENTITY

Eli Lilly & (LLY UN)

5
Analysis
Health CareUnited States
Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products for humans and animals. The Company products are sold in countries around the world. Eli Lilly products include neuroscience, endocrine, anti-infectives, cardiovascular agents, oncology, and animal health products.
more
bullishS&P 500 INDEX
08 Aug 2018 04:51

S&P 500: Outlook Constructive but Concerns Remain

As the S&P 500 nears the 2,873 January high - a critical hurdle - short-term Sector leadership changes give us reason for pause. While we...

Logo
304 Views
Share
bullishS&P 500 INDEX
30 Jul 2018 20:36

U.S. Vital Signs - Actionable Charts of the Day

Today's key points: Property & Casualty Insurance names are staging price and RS reversal and/or breakouts. Airlines are staging price and SR...

Logo
384 Views
Share
bullishEisai Co Ltd
26 Jul 2018 18:22

BAN2401 Detailed Data Presented at AAIC 2018 Validates Our Initial Concerns

Background - Eisai Co Ltd (4523 JP) on December 21, 2017, announced that 12 months data on BAN2401 did not meet its primary endpoint (link),...

bullishEisai Co Ltd
03 Jul 2018 20:11

Merck Alliance Provides Stability to Deal With the Outcome of High Risk Alzheimer’s R&D in FY19

We upgrade Eisai Co Ltd (4523 JP) to “Equal-weight” after reviewing our model post FY17 (YE Mar-18) earnings, in light of the augmented peak sales...

12 Apr 2018 23:44

A Conversation with Biogen

Biogen Inc (BIIB US) is Samsung Biologics Co., Ltd (207940 KS) 's minority (5.4%) partner in the Samsung Bioepis JV that manufactures and sells...

Share
x